WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

KOSDAQ:330350 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	107,861	92,943	128,366	123,616	138,481	189,477
Market Cap Growth	24.16%	-27.59%	3.84%	-10.73%	-26.91%	-
Enterprise Value	108,729	101,308	130,632	113,324	119,353	163,763
Last Close Price	8170.00	7040.00	9730.00	9270.64	10388.65	14147.75
PE Ratio	17.24	19.43	16.13	49.86	32.48	28.48
PS Ratio	1.06	0.91	1.60	1.91	2.41	3.55
PB Ratio	1.10	1.00	1.42	1.49	1.71	2.47
P/TBV Ratio	1.15	1.05	1.46	1.54	1.75	2.52
P/FCF Ratio	15.99	12.79	-	-	102.25	-
P/OCF Ratio	14.01	9.65	-	22.98	17.27	234.06
EV/Sales Ratio	1.06	0.99	1.63	1.75	2.08	3.07
EV/EBITDA Ratio	12.26	10.73	12.15	16.60	18.69	17.79
EV/EBIT Ratio	22.44	17.90	16.52	23.23	24.43	22.65
EV/FCF Ratio	16.11	13.94	-	-	88.13	-
Debt / Equity Ratio	0.23	0.26	0.22	0.26	0.29	0.22
Debt / EBITDA Ratio	2.51	2.55	1.86	3.14	3.62	1.87
Debt / FCF Ratio	3.30	3.31	-	-	17.06	-
Net Debt / Equity Ratio	0.01	0.06	0.10	-0.06	-0.24	-0.29
Net Debt / EBITDA Ratio	0.10	0.55	0.82	-0.75	-3.03	-2.41
Net Debt / FCF Ratio	0.13	0.71	-0.73	0.51	-14.30	4.99
Asset Turnover	0.75	0.77	0.64	0.54	0.51	-
Inventory Turnover	2.17	2.31	2.52	3.07	2.98	-
Quick Ratio	1.32	1.21	1.20	1.74	2.55	2.95
Current Ratio	1.93	1.80	1.88	2.33	3.19	3.64
Return on Equity (ROE)	6.56%	5.22%	9.19%	3.02%	5.41%	-
Return on Assets (ROA)	2.23%	2.67%	3.95%	2.56%	2.71%	-
Return on Invested Capital (ROIC)	4.52%	5.34%	7.78%	4.17%	6.84%	12.12%
Return on Capital Employed (ROCE)	4.60%	5.60%	7.90%	5.20%	5.10%	8.40%
Earnings Yield	5.81%	5.15%	6.20%	2.01%	3.08%	3.51%
FCF Yield	6.26%	7.82%	-9.38%	-8.05%	0.98%	-2.35%
Payout Ratio	-	27.57%	-	25.53%	9.90%	54.19%
Buyback Yield / Dilution	-0.27%	-0.00%	-0.09%	0.10%	-59.55%	-6.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.